A new market study reveals that the Global Diagnostic Software as a Medical Device (SaMD) and Radiogenomics Market is poised for rapid expansion, driven by the convergence of Artificial Intelligence (AI) with precision medicine. The market, valued at $1.98 billion in 2024, is expected to soar to $6.90 billion by 2032, reflecting a robust Compound Annual Growth Rate (CAGR) of 16.90% du... https://www.databridgemarketresearch.com/